Medarova相关文献与解析，生知库 | 链接生命科学的每一步

Co-administration of temozolomide (TMZ) and the experimental therapeutic targeting miR-10b, profoundly affects the tumorigenic phenotype of human glioblastoma cells

替莫唑胺 (TMZ) 与针对 miR-10b 的实验性治疗药物联合使用，对人类胶质母细胞瘤细胞的致瘤表型有显著影响

期刊:Frontiers in Molecular Biosciences

影响因子:3.9

doi:10.3389/fmolb.2023.1179343

Ming Chen, Bryan Kim, Neil Robertson, Sujan Kumar Mondal, Zdravka Medarova, Anna Moore

Clinical Applications of Short Non-Coding RNA-Based Therapies in the Era of Precision Medicine

精准医疗时代基于短链非编码RNA疗法的临床应用

期刊:Cancers

影响因子:4.4

doi:10.3390/cancers14061588

Smith, Ellen S; Whitty, Eric; Yoo, Byunghee; Moore, Anna; Sempere, Lorenzo F; Medarova, Zdravka

发表日期：2022

文献求助收藏

Case report: MicroRNA-10b as a therapeutic target in feline metastatic mammary carcinoma and its implications for human clinical trials

病例报告：MicroRNA-10b 作为猫转移性乳腺癌的治疗靶点及其对人体临床试验的影响

期刊:Frontiers in Oncology

影响因子:3.5

doi:10.3389/fonc.2022.959630

N Anna Savan, Paulo Vilar Saavedra, Alan Halim, Vilma Yuzbasiyan-Gurkan, Ping Wang, Byunghee Yoo, Matti Kiupel, Lorenzo Sempere, Zdravka Medarova, Anna Moore

Radiolabeling and PET-MRI microdosing of the experimental cancer therapeutic, MN-anti-miR10b, demonstrates delivery to metastatic lesions in a murine model of metastatic breast cancer

实验性癌症治疗药物 MN-anti-miR10b 的放射性标记和 PET-MRI 微剂量给药，证实其可递送至转移性乳腺癌小鼠模型中的转移性病变

期刊:Cancer Nanotechnology

影响因子:4.5

doi:10.1186/s12645-021-00089-5

Mariane Le Fur, Alana Ross, Pamela Pantazopoulos, Nicholas Rotile, Iris Zhou, Peter Caravan, Zdravka Medarova, Byunghee Yoo

MiRNA10b-directed nanotherapy effectively targets brain metastases from breast cancer

MiRNA10b 导向纳米疗法有效靶向乳腺癌脑转移

期刊:Scientific Reports

影响因子:3.8

doi:10.1038/s41598-021-82528-2

Byunghee Yoo, Alana Ross, Pamela Pantazopoulos, Zdravka Medarova

Role of microRNAs in glioblastoma

微小RNA在胶质母细胞瘤中的作用

期刊:Oncotarget

影响因子:

doi:10.18632/oncotarget.28039

Chen, Ming; Medarova, Zdravka; Moore, Anna

细胞生物学

发表日期：2021

文献求助收藏

Screening of potential miRNA therapeutics for the prevention of multi-drug resistance in cancer cells

筛选用于预防癌细胞多药耐药性的潜在 miRNA 疗法

期刊:Scientific Reports

影响因子:3.8

doi:10.1038/s41598-020-58919-2

Zdravka Medarova, Pamela Pantazopoulos, Byunghee Yoo

Nanotherapy Targeting miR-10b Improves Survival in Orthotopic Glioblastoma Models

靶向 miR-10b 的纳米疗法可提高原位胶质母细胞瘤模型的生存率

Monitoring of Nanodrug Accumulation in Murine Breast Cancer Metastases

监测纳米药物在小鼠乳腺癌转移灶中的积累

Inhibition of miR-10b treats metastatic breast cancer by targeting stem cell-like properties

抑制 miR-10b 通过靶向干细胞样特性治疗转移性乳腺癌

Co-administration of temozolomide (TMZ) and the experimental therapeutic targeting miR-10b, profoundly affects the tumorigenic phenotype of human glioblastoma cells

替莫唑胺 (TMZ) 与针对 miR-10b 的实验性治疗药物联合使用，对人类胶质母细胞瘤细胞的致瘤表型有显著影响

Clinical Applications of Short Non-Coding RNA-Based Therapies in the Era of Precision Medicine

精准医疗时代基于短链非编码RNA疗法的临床应用

Case report: MicroRNA-10b as a therapeutic target in feline metastatic mammary carcinoma and its implications for human clinical trials

病例报告：MicroRNA-10b 作为猫转移性乳腺癌的治疗靶点及其对人体临床试验的影响

Radiolabeling and PET-MRI microdosing of the experimental cancer therapeutic, MN-anti-miR10b, demonstrates delivery to metastatic lesions in a murine model of metastatic breast cancer

实验性癌症治疗药物 MN-anti-miR10b 的放射性标记和 PET-MRI 微剂量给药，证实其可递送至转移性乳腺癌小鼠模型中的转移性病变

MiRNA10b-directed nanotherapy effectively targets brain metastases from breast cancer

MiRNA10b 导向纳米疗法有效靶向乳腺癌脑转移

Role of microRNAs in glioblastoma

微小RNA在胶质母细胞瘤中的作用

Screening of potential miRNA therapeutics for the prevention of multi-drug resistance in cancer cells

筛选用于预防癌细胞多药耐药性的潜在 miRNA 疗法